Sponsor Pipeline

Martin T. King, MD, PhD Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
1
Active Trials
1
Recruiting
1
Disease Areas
Active Trials by Phase
Phase 2
1
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT07393867 Androgen-responsive POSLUMA-guided Intra-prostatic Boost Intermediate Risk Prostate Cancer Recruiting
Disease Areas
Prostate Cancer (1)
Get alerts when Martin T. King, MD, PhD's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free